Aclaris Therapeutics Price Chart
Aclaris Therapeutics Volume Chart
Aclaris Therapeutics Market Segments
After Hours
*No Trades in Segment
Regular Trading Hours
+0.02(+0.57%)
| Open | $3.50 |
|---|---|
| Close | $3.52 |
| Low | $3.40 |
| Low Change | -0.10 (-2.86%) |
| High | $3.61 |
| High Change | +0.11 (+3.00%) |
| Range | $0.21 |
| Volume | 2.302M |
| Dollar Volume | $8.10M |
Premarket
+0.00(+0.00%)
| Open | $3.52 |
|---|---|
| Close | $3.52 |
| Low | $3.52 |
| Low Change | 0.00 (0.00%) |
| High | $3.52 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 100 |
| Dollar Volume | $352.00 |
After Hours Yesterday
+0.05(+1.43%)
| Open | $3.50 |
|---|---|
| Close | $3.55 |
| Low | $3.47 |
| Low Change | -0.03 (-0.86%) |
| High | $3.55 |
| High Change | +0.05 (+1.43%) |
| Range | $0.08 |
| Volume | 59.329K |
| Dollar Volume | $210.62K |
Regular Trading Hours Yesterday
+0.00(+0.00%)
| Open | $3.53 |
|---|---|
| Close | $3.53 |
| Low | $3.44 |
| Low Change | -0.09 (-2.55%) |
| High | $3.60 |
| High Change | +0.07 (+1.98%) |
| Range | $0.16 |
| Volume | 1.346M |
| Dollar Volume | $4.75M |
Premarket Yesterday
+0.08(+2.29%)
| Open | $3.50 |
|---|---|
| Close | $3.58 |
| Low | $3.39 |
| Low Change | -0.11 (-3.14%) |
| High | $3.64 |
| High Change | +0.14 (+4.00%) |
| Range | $0.25 |
| Volume | 6.933K |
| Dollar Volume | $24.82K |
Aclaris Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $3.54 |
|---|---|
| 10 Day Moving Average (SMA10) | $3.63 |
| 20 Day Moving Average (SMA20) | $3.44 |
| 50 Day Moving Average (SMA50) | $3.47 |
| 100 Day Moving Average (SMA100) | $3.12 |
| 200 Day Moving Average (SMA200) | $2.44 |
Aclaris Therapeutics Statistics
| Average Volume (30 Days) | 2.26M |
|---|---|
| P/E Ratio (Current) | -6.65 |
| EPS (Current) | -$0.54 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$47.22M |
| Cash Ratio | 0.70 |
| Current Ratio | 3.36 |
| Quick Ratio | 3.36 |
| Debt to Equity | 0.00 |
| Enterprise Value | $414.74M |
| EV to EBITDA | -5.63 |
| EV to Sales | 53.00 |
| Price to Book | 4.22 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 55.55 |
| Return on Assets | -0.40% |
| Return on Equity | -0.63% |
Aclaris Therapeutics Stock Splits
There have been no stock splits for Aclaris Therapeutics (ACRS).
Aclaris Therapeutics Dividends
There have been no dividends for Aclaris Therapeutics (ACRS).